1. Sussman, Django, Smith, Leia M, Anderson, Martha E, Whiting, Nancy, Benjamin, Dennis R. 2014. SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer. In Molecular cancer therapeutics, 13, 2991-3000. doi:10.1158/1535-7163.MCT-13-0896. https://pubmed.ncbi.nlm.nih.gov/25253783/
2. Cui, Xiao-Bin, Shen, Yao-Yuan, Jin, Ting-Ting, Chen, Yun-Zhao, Li, Feng. 2015. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma. In Journal of translational medicine, 13, 321. doi:10.1186/s12967-015-0681-z. https://pubmed.ncbi.nlm.nih.gov/26444413/
3. Andres, Sarah A, Brock, Guy N, Wittliff, James L. 2013. Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. In BMC cancer, 13, 326. doi:10.1186/1471-2407-13-326. https://pubmed.ncbi.nlm.nih.gov/23819905/
4. Wan, Zhen, Wang, Xuzhen. 2022. Role of SLC39A6 in the development and progression of liver cancer. In Oncology letters, 23, 77. doi:10.3892/ol.2022.13197. https://pubmed.ncbi.nlm.nih.gov/35111246/
5. Cheng, Xinxin, Wei, Lixuan, Huang, Xudong, Lin, Dongxin, Wu, Chen. 2017. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis. In Gastroenterology, 152, 1985-1997.e12. doi:10.1053/j.gastro.2017.02.006. https://pubmed.ncbi.nlm.nih.gov/28209530/
6. Tang, Mingzheng, Rong, Yao, Li, Xiaofeng, Liu, Zhilong, Cai, Hui. 2024. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. In BMC cancer, 24, 1163. doi:10.1186/s12885-024-12830-5. https://pubmed.ncbi.nlm.nih.gov/39300389/
7. Zhao, Lei, Tan, Jiaqi, Li, Dan, Wang, Jue, Zhou, Jianfeng. 2019. SLC39A6/ZIP6 is essential for zinc homeostasis and T-cell development in zebrafish. In Biochemical and biophysical research communications, 511, 896-902. doi:10.1016/j.bbrc.2019.02.148. https://pubmed.ncbi.nlm.nih.gov/30851936/
智鼠故事 
